Encompass Wealth Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Encompass Wealth Advisors's LLY Position: Q2 2026 in Review
Encompass Wealth Advisors reduced its Eli Lilly (LLY) stake by 4.1% in Q2 2026, selling an estimated $28.6K and leaving 648 shares worth $777K. The position accounts for 0.24% of the portfolio, ranked #51.
Encompass Wealth Advisors first reported a position in LLY in Q1 2024 and has held it in 8 quarters since. The position peaked at $1.95M in Q1 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Encompass Wealth Advisors held 648 shares of Eli Lilly worth $777K as of Q2 2026.
- Encompass Wealth Advisors sold 28 Eli Lilly shares in Q2 2026, an estimated $28.6K.
- Eli Lilly made up 0.24% of Encompass Wealth Advisors's portfolio in Q2 2026, its #51 holding.
- Encompass Wealth Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 8 quarters since.
- Encompass Wealth Advisors's Eli Lilly position peaked at $1.95M in Q1 2024.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Encompass Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.